Zogenix: FDA Greenlights UCB Drug for Severe Form of Epilepsy

UCB's Fintepla (fenfluramine) oral solution CIV was approved in the United States for the treatment of seizures associated with Lennox-Gastaut syndrome in patients two years of age and older. Additionally, the FDA granted pediatric exclusivity for the product.